Rod Chisholm Memorial Donation Page
September 1, 1964 – July 30, 2021
Roderick Neil Chisholm passed away after a courageous battle with brain cancer (Glioblastoma).
Born in Scotland, Rod’s Family immigrated to Canada in 1975 making their home in Saskatoon, Saskatchewan. After completing his degree in Mechanical Engineering at the University of Saskatchewan, Rod moved to Banff to pursue his love of the mountains and downhill skiing.
Rod’s ski industry career spanned 36 years. It began and ended at Sunshine Village. Originally joining in 1985 as a gondola operator, Rod's hardworking and intelligent spirit was rewarded in the company. His career culminated as the Vice President of Mountain Operations and Maintenance. Rod described his team and coworkers at Banff Sunshine Village as family.
In his honour, friends and family have rallied to establish the Rod Chisholm Memorial Fund to support glioblastoma research at the University of Calgary’s Cumming School of Medicine. All donations made by August 31st, 2022 will be generously matched by Banff Sunshine Village.
Donations made through this page will go directly towards supporting important research discoveries – your support will help change the course of cancer care and treatment in Alberta and beyond. Thank you very much for the consideration to donate.
All gifts are eligible to receive a tax receipt through the University of Calgary.
About University of Calgary (UCalgary) Glioblastoma Research:
Glioblastoma (GBM) is the most common and aggressive subtype of brain tumour, with symptoms ranging from seizures, headaches, and memory loss to changes in personality. GBM also resists the tumour-controlling effects of chemotherapy and radiation, making it one of the few cancers to escape major advances in treatment. Finding a cure is one of the biggest challenges facing clinicians and scientists.
Yet despite these staggering facts and statistics, there is hope for GBM patients now and in the future. UCalgary researchers within the Arnie Charbonneau Cancer Institute have made great strides in changing how GBM is understood and developing better treatment options. With the support of philanthropy, we have continued to build upon our collaborative and multi-disciplinary strengths to focus on understanding how to prevent drug resistance in GBM and how to target metabolic changes to improve treatment.